Richard Paul Bryce is VP at PUMA BIOTECHNOLOGY, INC. (PBYI). They have made 36 open-market trades across 1 company since 2014, most recently 2021-04-05.
CIK 0001553037
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2K since 2014, against 35 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PBYI | 121,662 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2021-04-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PBYI | SELL | 2021-04-05 | 2021-04-06 | $9.80 | $4K | +4.6% | +0.5% | -9.7% |
| PBYI | SELL | 2021-03-02 | 2021-03-04 | $10.15 | $4K | +2.5% | -7.5% | +0.3% |
| PBYI | SELL | 2021-02-02 | 2021-02-03 | $12.23 | $5K | -6.3% | -13.1% | -21.5% |
| PBYI | SELL | 2021-01-04 | 2021-01-06 | $10.23 | $134K | +4.1% | +15.6% | -8.4% |
| PBYI | SELL | 2020-12-02 | 2020-12-04 | $11.65 | $1K | -4.3% | -10.8% | -7.6% |
| PBYI | SELL | 2020-11-02 | 2020-11-03 | $7.81 | $758 | +12.9% | +53.4% | +53.4% |
| PBYI | SELL | 2020-10-02 | 2020-10-05 | $10.14 | $923 | -5.0% | -15.1% | +0.3% |
| PBYI | SELL | 2020-09-02 | 2020-09-03 | $9.77 | $879 | +3.7% | +4.7% | +18.4% |
| PBYI | SELL | 2020-08-03 | 2020-08-05 | $10.80 | $929 | -2.1% | -11.0% | -26.7% |
| PBYI | SELL | 2020-07-02 | 2020-07-06 | $10.67 | $7K | -7.8% | +2.7% | -4.5% |
| PBYI | SELL | 2020-06-02 | 2020-06-03 | $10.66 | $949 | -12.9% | -2.3% | -10.6% |
| PBYI | SELL | 2020-05-04 | 2020-05-06 | $9.62 | $856 | +19.1% | -2.9% | -1.4% |
| PBYI | SELL | 2020-04-02 | 2020-04-03 | $7.37 | $671 | +15.6% | +39.0% | +41.5% |
| PBYI | SELL | 2020-03-02 | 2020-03-03 | $10.02 | $962 | -28.2% | -30.7% | -0.2% |
| PBYI | SELL | 2020-02-03 | 2020-02-04 | $8.02 | $842 | +11.3% | +3.0% | -6.1% |
| PBYI | SELL | 2020-01-02 | 2020-01-03 | $8.40 | $13K | +1.3% | -2.5% | -10.9% |
| PBYI | SELL | 2019-12-02 | 2019-12-03 | $10.34 | $858 | -1.3% | -11.1% | +12.8% |
| PBYI | SELL | 2019-11-04 | 2019-11-05 | $7.38 | $649 | +10.4% | +3.2% | +11.5% |
| PBYI | SELL | 2019-10-02 | 2019-10-03 | $10.05 | $915 | -33.2% | -28.4% | -17.1% |
| PBYI | SELL | 2019-09-04 | 2019-09-05 | $10.11 | $960 | +6.6% | -8.0% | -18.2% |
| PBYI | SELL | 2019-08-02 | 2019-08-05 | $9.00 | $846 | +6.7% | +18.0% | -17.6% |
| PBYI | SELL · 10b5-1 | 2019-07-22 | 2019-07-24 | $10.10 | $19K | -9.4% | +13.8% | -27.3% |
| PBYI | SELL | 2019-07-02 | 2019-07-03 | $12.78 | $1K | -15.8% | -29.9% | -20.6% |
| PBYI | SELL | 2019-06-03 | 2019-06-05 | $15.07 | $1K | -5.2% | -14.9% | -27.4% |
| PBYI | SELL | 2019-05-02 | 2019-05-06 | $32.38 | $3K | -46.4% | -54.1% | -72.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.